Browsing ODA Open Digital Archive by Journals "Acta Oncologica"
Now showing items 1-5 of 5
-
Anticancer therapy at end-of-life: A retrospective cohort study
(Peer reviewed; Journal article, 2024)Background: A significant proportion of patients with incurable cancer receive systemic anticancer therapy (SACT) within their last 30 days of life (DOL). The treatment has questionable benefit, nevertheless is considered ... -
Longitudinal kidney function outcome in aging testicular cancer survivors
(Acta Oncologica;Volume 59, 2020 - Issue 4, Journal article; Peer reviewed, 2020-02-11)Purpose: Testicular cancer survivors (TCSs) have increased risk of reduced kidney function related to treatment burden, but longitudinal studies of renal outcome in aging TCSs have been lacking. This longitudinal study ... -
Myelosuppression in patients treated with 177Lutetium-lilotomab satetraxetan can be predicted with absorbed dose to the red marrow as the only variable
(Acta Oncologica;Volume 60, 2021 - Issue 11, Peer reviewed; Journal article, 2021-08-23)Background: The aim of this study was to investigate dosimetry data and clinical variables to predict hematological toxicity in non-Hodgkin lymphoma (NHL) patients treated with [177Lutetium]Lu-liloto-mab satetraxetan. Material ... -
Terminal digit preference: a source of measurement error in breast cancer diameter reporting
(Acta Oncologica;Published online 30 Sep 2019, Journal article; Peer reviewed, 2019-09-14)Objectives: Women diagnosed with breast cancer are offered treatment and therapy based on tumor characteristics, including tumor diameter. There is scarce knowledge whether tumor diameter is accurately reported, or whether ... -
Thyroid hypofunction in aging testicular cancer survivors
(Peer reviewed; Journal article, 2021)Purpose Thyroid hypofunction is a late effect observed in several groups of cancer survivors, but has to date not been evaluated in-depth in testicular cancer survivors (TCSs). We investigated the prevalence of thyroid ...